New York, New York (PRWEB) February 24, 2013
Actos lawsuits continue to move forward in the federal multidistrict litigation underway in U.S. District Court, Western District of Louisiana. According to a Scheduling Order dated February 19, 2013, the Court has established a Pilot Bellwether Program, which sets up a stream-lined selection process for a minimum of two Pilot Bellwether trials. The Order stipulates that the litigation’s first Pilot Bellwether trial will begin on January 27, 2014, while the second will commence on April 14, 2014. Attorneys for both sides have been directed to nominate five Actos lawsuits each to participate in the Pilot Bellwether Discovery Pool by April 1, 2013.* (In re: Actos Product Liability Litigation, MDL No. 2299)
“The bellwether trials will provide valuable insight into how juries might weigh similar Actos claims. We look forward to this process getting underway,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently offering free Actos bladder cancer lawsuit evaluations to individuals who may have been harmed by the medication.
Actos Bladder Cancer Lawsuits
Actos, known generically as pioglitazone, is approved as a treatment for type 2 diabetes. The U.S. Food & Drug Administration (FDA) ordered Takeda Pharmaceuticals to add new warnings to the Actos label in June 2011, after a study found that long-term use of the drug increased the risk for bladder cancer.* Since then, hundreds of people have filed Actos bladder cancer lawsuits alleging long-term use of the drug caused them to develop the disease.
The nation’s first trial involving an Actos bladder cancer lawsuit is now underway in Los Angeles Superior Court. According to a recent report
Copyright©2012 Vocus, Inc.
All rights reserved